AHK-Cu Topical Peptide

AHK-Cu is a copper-binding tripeptide analog of GHK-Cu optimized for hair follicle targeting. The AHK sequence shows enhanced affinity for follicular dermal papilla cells, stimulating Wnt/beta-catenin signaling for hair growth cycle regulation.

AHK-Cu (alanyl-histidyl-lysine copper complex) is a synthetic tripeptide-copper complex composed of three amino acids — alanine, histidine, and lysine — chelated to a divalent copper ion (Cu²⁺). The histidine imidazole nitrogen and the deprotonated amide nitrogen of the peptide backbone form the primary coordination sphere around copper, generating a stable square-planar complex. This coordination geometry mirrors the structural motif found in the better-characterised GHK-Cu (glycyl-histidyl-lysine copper) complex, which is recognised as the bioactive copper-delivery vehicle of the SPARC/osteonectin family of matrix-modulating peptides.

Copper Delivery to Dermal and Follicular Tissue

The principal mechanism attributed to AHK-Cu in topical research is the controlled delivery of copper ions to keratinocytes, dermal fibroblasts, and the dermal papilla cells of the hair follicle. Copper is an essential cofactor for lysyl oxidase (LOX), superoxide dismutase 1 (SOD1), cytochrome c oxidase, and tyrosinase. By providing a bioavailable, lipophilic-compatible copper source, AHK-Cu has been investigated in preclinical models for its ability to modulate extracellular matrix remodelling and antioxidant defence in cutaneous tissue.

Hair Follicle Signalling

In ex vivo human hair follicle organ culture models, AHK-Cu has been associated with the prolongation of the anagen (growth) phase and a delay of catagen progression. Proposed downstream signalling effects include upregulation of vascular endothelial growth factor (VEGF) expression in dermal papilla cells, which supports perifollicular angiogenesis, and modulation of the Wnt/β-catenin axis governing follicular stem cell activation. Increased proliferation of outer root sheath keratinocytes has also been reported in cell culture studies using AHK-Cu at micromolar concentrations.

Extracellular Matrix Modulation

Like GHK-Cu, AHK-Cu has been investigated for its capacity to influence dermal collagen and glycosaminoglycan synthesis. Copper-dependent activation of lysyl oxidase catalyses the cross-linking of collagen and elastin fibres, contributing to dermal tensile properties. Research has also examined potential effects on metalloproteinase regulation, including tissue inhibitors of metalloproteinases (TIMPs), suggesting a balanced remodelling profile rather than purely anabolic activity.

Antioxidant and Anti-Inflammatory Pathways

Copper-peptide complexes have been studied for their ability to scavenge reactive oxygen species (ROS) and to support endogenous antioxidant enzyme function. By contributing copper to SOD1, AHK-Cu may indirectly enhance superoxide dismutation in cells exposed to oxidative stress. Preclinical observations suggest possible attenuation of inflammatory cytokine release in keratinocyte cultures, although the AHK-Cu literature remains less developed than that of GHK-Cu.

Comparison with GHK-Cu

The substitution of alanine for glycine at the N-terminus subtly alters the steric and electronic environment around the copper-binding site. Some researchers have suggested that this modification may shift tissue-distribution preferences toward follicular structures, although direct comparative data are limited. Both compounds remain investigational tools used in dermal and follicular research, with neither approved for human therapeutic use.

AHK-Cu Topical is a multi-component research formulation built around the alanyl-histidyl-lysine copper tripeptide complex in a topical-compatible vehicle. The formulation is intended exclusively for laboratory research on dermal and follicular tissue models. The table below describes the principal characterised components.

Formulation Notes

• Active class: Copper-peptide chelate (tripeptide-1 copper analog)
• Physical form: Topical solution, typically pale blue due to the copper-peptide chromophore
• Concentration: Research-typical range 0.05%–0.2% w/v AHK-Cu in vehicle
• Compatibility: Avoid co-formulation with strong reducing agents (e.g., high-concentration ascorbic acid) or thiol compounds, which can disrupt copper coordination
• Purity reference: Component peptide ≥98% by HPLC prior to chelation

Because AHK-Cu Topical is a multi-ingredient formulation, no single molecular formula, CAS number, or molecular weight describes the finished product. Each batch is characterised by component identity, copper content, and pH. Researchers should consult the batch-specific Certificate of Analysis (COA) for exact composition.

AHK-Cu Topical is supplied as a pre-formulated aqueous or hydroalcoholic solution containing the alanyl-histidyl-lysine copper tripeptide complex along with stabilizing excipients. Because the active component is a copper-bound peptide, proper handling preserves the integrity of the metal-peptide coordination and prevents oxidation or precipitation of the complex.

Pre-Use Inspection

1. Inspect the bottle for the characteristic pale blue tint of the copper-peptide complex. Color loss, browning, or visible precipitate may indicate oxidation or destabilization.
2. Gently invert the bottle several times to ensure homogeneous distribution. Do not shake vigorously, as mechanical agitation can disrupt the copper coordination sphere and degrade the active complex.
3. Allow the solution to equilibrate to room temperature (18-22°C) before use if it has been stored refrigerated.

Application Protocol for Research Studies

1. For ex vivo follicle culture studies, dilute the topical solution in serum-free William's E medium or equivalent at a final AHK-Cu concentration of 1-10 nM.
2. For in vivo scalp application research, apply a measured volume (typically 0.5-1.0 mL) directly to the scalp area under investigation using a dropper or pipette.
3. Allow full absorption before any further application of additional study compounds.
4. Record the exact volume, concentration, and application schedule for reproducibility.

Compatibility and Incompatibility Notes

AHK-Cu is incompatible with strong reducing agents such as high-concentration ascorbic acid (vitamin C) and thiol-containing compounds (e.g., glutathione, N-acetylcysteine), which can reduce Cu²⁺ to Cu⁺ and disrupt the peptide-copper complex. If co-application with antioxidants is part of the research protocol, separate application by at least 30 minutes or use sequential rather than mixed dosing. AHK-Cu is generally compatible with hyaluronic acid, niacinamide, and most humectants commonly used in cosmetic research formulations.

Personal Protective Equipment

Standard laboratory PPE including nitrile gloves and safety eyewear should be used during handling. While topical copper peptide formulations are generally considered low-hazard, prolonged or repeated skin contact outside intended study parameters should be avoided. Wash any incidental skin exposure with water.

For Research Use Only

AHK-Cu Topical is supplied for in vitro and ex vivo research, as well as controlled topical scalp research investigations. It is not approved as a drug and is not intended for therapeutic use, diagnosis, or prevention of any condition.

Proper storage of AHK-Cu Topical is critical to maintain the integrity of the copper-peptide complex, which is susceptible to oxidation, precipitation, and microbial contamination over time. The following parameters reflect best practices for research-grade copper tripeptide formulations.

Unopened Storage

Store unopened bottles refrigerated at 2-8°C for long-term stability. Under these conditions, sealed AHK-Cu Topical formulations typically retain full activity for 18-24 months from the date of manufacture, depending on the stabilizing excipient system used. Avoid freezing, as ice crystal formation can disrupt the peptide-copper coordination and cause irreversible precipitation upon thawing.

In-Use Storage

Once opened, AHK-Cu Topical should be kept refrigerated between uses and used within 60-90 days to ensure consistent peptide concentration and copper coordination. Ensure the cap or dropper is fully closed after each use to minimize air exposure and evaporative concentration changes.

Short-Term Handling and Transit

Brief exposure to ambient room temperature (up to 25°C) for up to 14 days during shipping or transfer between research sites does not significantly degrade the active complex when the product remains in its original sealed packaging. Avoid temperatures above 30°C and direct sunlight, which can accelerate oxidation of the copper-peptide complex and yellowing of the solution.

Light Sensitivity

Copper peptide complexes are mildly photosensitive. Store in the original amber or opaque container, and avoid prolonged exposure to direct light or UV radiation. If transferring aliquots for research use, use amber glass vials.

Stability Indicators

A stable AHK-Cu Topical solution should retain its characteristic pale blue color and remain clear, free of precipitate or turbidity. Color changes (browning, greening, or loss of blue tint), visible particulates, or unusual odor indicate degradation, and the product should not be used in research applications requiring quantitative reproducibility.

Disposal

Dispose of expired or degraded product according to institutional guidelines for cosmetic peptide and trace-metal-containing solutions. Do not pour large volumes down drains without checking local environmental regulations regarding copper-containing waste.